Improvement of health-related quality of life after 3 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
C. Gessner (Leipzig, Germany), B. Akyildiz (Hamburg, Germany), M. Martini (Hamburg, Germany), T. Meyer-Duderstaedt (Hamburg, Germany), R. Koczulla (Marburg, Germany)
Source: International Congress 2022 – Asthma treatment: real-world studies and other diseases
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Gessner (Leipzig, Germany), B. Akyildiz (Hamburg, Germany), M. Martini (Hamburg, Germany), T. Meyer-Duderstaedt (Hamburg, Germany), R. Koczulla (Marburg, Germany). Improvement of health-related quality of life after 3 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany. 1329
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|